Insurance Approval Delay of Biologic Therapy Dose Escalation Associated with Disease Activity in Patients with Inflammatory Bowel Disease
Nisha Shah, Autumn D. Zuckerman, Katie R. Hosteng, Jessica Fann, Josh DeClercq, Leena Choi, Laura Cherry, David A. Schwartz, Sara Horst
Topics & Concepts
MedicineInterquartile rangePharmacyInternal medicineInstitutional review boardInflammatory bowel diseaseRetrospective cohort studyDiseaseBiosimilarEmergency medicineSurgeryFamily medicineInflammatory Bowel DiseaseBiosimilars and Bioanalytical MethodsMedication Adherence and Compliance